Juggling a soccer ball has long been California resident Hollis Belger’s way of bringing people together and raising awareness and funds for St. Jude Children’s Research Hospital®. Now, with the world ...
Transposons, DNA sequences that can self-replicate and move (jump) throughout the genome, are widespread and can affect cell survival if left unchecked. Cells control these “jumping genes” by ...
Lorna Renner, MD, of the University of Ghana Medical School. Krisha Sharma, MD, B P Koirala Memorial Cancer Hospital senior consultant and board of directors member in Nepal. The Global Platform for ...
My family loves traveling. During the COVID-19 pandemic, we started a tradition of visiting national parks. Long road trips became our thing. At this point, our two kids have been to 50 of them!
Preclinical results from St. Jude Children’s Research Hospital show that an RNA-targeted therapy can restore function in a model of an ultrarare disease. HNRNPH2-related neurodevelopmental disorder is ...
A collaboration between St. Jude Children’s Research Hospital and the University of Utah has led to the development of μPharma, an AI-driven microfluidics platform for single-day drug efficacy ...
The platform integrates multi-omics and clinical outcome datasets from nearly 6,000 patients to enable deeper analysis of blood cancers. Scientists at St. Jude Children’s Research Hospital, the ...
The wood table with its keepsakes occupies a special corner of their home, a tribute to Thiago. And it never looks the same — it changes over time. “We keep adding toys or figurines he would have ...
The infant immune system is fundamentally different from that of adults, and its unique vulnerabilities to infections make specialized research essential for developing effective protection strategies ...
I was lying on my bed, hanging out on TikTok one night in December when my mom came in my room and was like, “Hey, whatcha doing? Do you know who Megan Moroney is?” I was like, “Ummm, yes.” I only ...
Ewing sarcoma is a pediatric cancer that generally responds well to initial therapies. This is due to the high expression of SLFN11, a DNA damage response protein that confers a vulnerability to ...
ALSAC also announced that Deborah “Deb” Garcia has joined the executive leadership team as senior vice president of strategy. Garcia, who brings an exceptional track record of success at a global ...